KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

TherapeuticsMD (TXMD) Asset Utilization Ratio (2016 - 2025)

Historic Asset Utilization Ratio for TherapeuticsMD (TXMD) over the last 13 years, with Q3 2025 value amounting to 0.07.

  • TherapeuticsMD's Asset Utilization Ratio rose 8086.98% to 0.07 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.07, marking a year-over-year increase of 8086.98%. This contributed to the annual value of 0.04 for FY2024, which is 12028.77% up from last year.
  • Latest data reveals that TherapeuticsMD reported Asset Utilization Ratio of 0.07 as of Q3 2025, which was up 8086.98% from 0.07 recorded in Q2 2025.
  • In the past 5 years, TherapeuticsMD's Asset Utilization Ratio registered a high of 1.33 during Q3 2023, and its lowest value of 0.03 during Q2 2024.
  • Moreover, its 5-year median value for Asset Utilization Ratio was 0.32 (2022), whereas its average is 0.37.
  • Per our database at Business Quant, TherapeuticsMD's Asset Utilization Ratio skyrocketed by 83044.05% in 2023 and then tumbled by 9782.36% in 2024.
  • Quarter analysis of 5 years shows TherapeuticsMD's Asset Utilization Ratio stood at 0.46 in 2021, then surged by 35.95% to 0.62 in 2022, then plummeted by 95.19% to 0.03 in 2023, then skyrocketed by 49.69% to 0.04 in 2024, then surged by 61.24% to 0.07 in 2025.
  • Its Asset Utilization Ratio was 0.07 in Q3 2025, compared to 0.07 in Q2 2025 and 0.05 in Q1 2025.